Journal of Cancer Survivorship

, Volume 6, Issue 4, pp 407–419

The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement

Authors

    • Division of Cancer Control and Population SciencesNational Cancer Institute
    • Health Services and Economics Branch/Applied Research ProgramNational Cancer Institute
  • Emily Dowling
    • Division of Cancer Control and Population SciencesNational Cancer Institute
    • Institute for Technology AssessmentMassachusetts General Hospital
  • Juan Rodriguez
    • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health PromotionCenters for Disease Control and Prevention
  • Donatus U. Ekwueme
    • Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health PromotionCenters for Disease Control and Prevention
  • Helen Meissner
    • Office of Behavioral and Social Sciences ResearchNational Institutes of Health
  • Anita Soni
    • Center for Financing, Access, and Cost TrendsAgency for Healthcare Research and Quality
  • Catherine Lerro
    • Health Services Research Program, Intramural Research DepartmentAmerican Cancer Society National Home Office
  • Gordon Willis
    • Division of Cancer Control and Population SciencesNational Cancer Institute
  • Laura P. Forsythe
    • Division of Cancer Control and Population SciencesNational Cancer Institute
  • Laurel Borowski
    • Division of Cancer Control and Population SciencesNational Cancer Institute
  • Katherine S. Virgo
    • Health Services Research Program, Intramural Research DepartmentAmerican Cancer Society National Home Office
Policy Papers

DOI: 10.1007/s11764-012-0221-2

Cite this article as:
Yabroff, K.R., Dowling, E., Rodriguez, J. et al. J Cancer Surviv (2012) 6: 407. doi:10.1007/s11764-012-0221-2

Abstract

Introduction

The prevalence of cancer survivorship in the USA is expected to increase in the future because the US population is increasing in size and is aging and because survival following diagnosis is improving for many types of cancer. Medical care costs associated with cancer are also projected to increase dramatically. However, currently available data for estimating medical care costs and other important aspects of the burden of cancer, including time spent receiving medical care, productivity loss due to morbidity for patients and their families, and financial hardship, are limited, particularly in the population under the age of 65.

Methods

We describe selected publicly available data sources for estimating the burden of cancer in the USA and a new collaborative effort to improve the quality of these data: the nationally representative Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement.

Conclusions

Data from this effort can be used to address key gaps in cancer survivorship research related to medical care costs, employment patterns, financial hardship, and other aspects of the burden of illness for cancer survivors and their families.

Implications for cancer survivors

Research using the MEPS Experiences with Cancer Survivorship Supplement can inform efforts by health care policy makers, healthcare systems, providers, and employers to improve the cancer survivorship experience in the USA.

Keywords

Cost of illness Health care expenditures Burden of illness Neoplasms SEER-Medicare NHIS MEPS

Copyright information

© Springer Science+Business Media, LLC (outside the USA)  2012